MiR-143 overexpression was shown to enhance the sensitivity of AML cells to the cytotoxicity of cytarabine (Ara-C) treatment by inhibiting autophagy through ATG7 and ATG2B targeting [116]. Here, ATG7 is linked to acute myeloid leukemia.